Descripción
La descripción detallada está siendo preparada por nuestro equipo clínico.
Ensayos Clínicos
NCT06484556
Fase 1
Reclutando
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
China
NCT06484790
Fase 1
Reclutando
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
China
NCT06478251
Fase 1
Reclutando
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
China
NCT07474168
Fase 1
Activo, no reclutando
T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
China
NCT06956261
Fase 1
Aún no recluta
NW-301 TCR-T in Patients With Advanced Solid Tumor
China